Tenon Medical, Inc.

NasdaqCM TNON

Tenon Medical, Inc. Price to Earnings Ratio (P/E) on January 14, 2025: -0.38

Tenon Medical, Inc. Price to Earnings Ratio (P/E) is -0.38 on January 14, 2025, a -31.23% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Tenon Medical, Inc. 52-week high Price to Earnings Ratio (P/E) is -0.10 on August 16, 2024, which is 74.17% above the current Price to Earnings Ratio (P/E).
Tenon Medical, Inc. 52-week low Price to Earnings Ratio (P/E) is -1.74 on September 16, 2024, which is -356.75% below the current Price to Earnings Ratio (P/E).
Tenon Medical, Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is -0.38.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

NasdaqCM: TNON

Tenon Medical, Inc.

CEO	Mr. Steven M. Foster
IPO Date	April 27, 2022
Location	United States
Headquarters	104 Cooper Court
Employees	21
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.

Key trends

Past 5 years